125
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Influence of liposomal formulation variables on the interaction with Candida albicans in biofilm; a multivariate approach

, , &
Pages 9-16 | Received 20 Oct 2009, Accepted 17 Jan 2010, Published online: 02 Mar 2010

References

  • Baillie, G. S., Douglas, L. J. (1999). Role of dimorfism in the development of Candida albicans biofilms. J Med Microbiol 48:671–679.
  • Birudaraj, R., Mahalingam, R., Li, X., Jasti, B. R. (2005). Advances in buccal drug delivery. Crit Rev Ther Drug Carr Syst 22:295–330.
  • Cevc, G. (1993). Phospholipids handbook. New York: Dekker.
  • Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., Ghannoum, M. A. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385–5394.
  • Clarkson, J. E., Worthington, H. V., Eden, O. B. (2007). Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev Art. no.: CD003807.
  • Costerton, J. W., Stewart, P. S., Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322.
  • Ellepola, A. N. B., Samaranayake, L. P. (2000). Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 11:172–198.
  • Erjavec, V., Pavlica, Z., Sentjurc, M., Petelin, M. (2006). In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry. Int J Pharm 307:1–8.
  • Farshi, F. S.,Özer, A. Y., Ercan, M. T., Hincal, A. A. (1996). In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. J Microencaps 13:537–544.
  • Filion, M. C., Phillips, N. C. (1997). Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids towards immune effector cells. Biochim Biophys Acta 1329:345–356.
  • Gandhi, R. B., Robinson, J. R. (1994). Oral cavity as a site for bioadhesive drug delivery. Adv Drug Del Rev 13:43–74.
  • Hao, J., Heng, P. W. S. (2003). Buccal delivery systems. Drug Dev Ind Pharm 29:821–832.
  • Harsanyi, B. B., Hilchie, J. C., Mezei, M. (1986). Liposomes as drug carriers for oral ulcers. J Dent Res 65:1133–1141.
  • Holmes, A. R., Cannon, R. D., Shepherd, M. G. (1992). Mechanisms of aggregation accompanying morphogenesis in Candida albicans. Oral Microbiol Immunol 7:32–37.
  • Ibrahim, A. S., Mirbod, F., Filler, S. G., Banno, Y., Cole, G. T., Kitajima, Y., et al. (1995). Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63:1993–1998.
  • Jin, Y., Yip, H. K., Samaranayake, Y. H., Yau, J. Y., Samaranayake, L. P. (2003). Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 41:2961–2967.
  • Li, X., Yan, Z., Xu, J. (2003). Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353–362.
  • Li, X. Z., Hauer, B., Rosche, B. (2007). Single-species microbial biofilm screening for industrial applications. Appl Microbiol Biotechnol 76:1255–1262.
  • Mayhew, E., Gotfredsen, C., Schneider, Y., Trouet, A. (1980). Interaction of liposomes with cultured cells: effect of serum. Biochem Pharmacol 29:877–886.
  • Petelin, M., Sentjurc, M., Stolic, Z., Skaleric, U. (1998). EPR study of mucoadhesive ointments for delivery of liposomes into the oral mucosa. Int J Pharm 173:193–202.
  • Potera, C. (1999). Microbiology: forging a link between biofilm and disease. Science 283:1837–1839.
  • Ramage, G., Walle, K. V., Wickes, B. L., López-Ribot, J. L. (2001). Biofilm formation by Candida dubliniensis. J Clin Microbiol 39:3234–3240.
  • Ramage, G., Saville, S. P., Thomas, D. P., López-Ribot, J. L. (2005). Candida biofilms: an update. Eucaryot Cell 4:633–638.
  • Reboiras, M. D., Miller, M. J., Jones, M. N. (1997). Liposomes adsorption to Candida albicans. Coll Surf B Biointerf 9:101–107.
  • Schaller, M., Borelli, C., Korting, H., Hube, B. (2005). Hydrolytic enzymes as virulence factors of Candida albicans. Mycosis 48:365–377.
  • Schwach-Abdellaoui, K., Vivien-Castioni, N., Gurny, R. (2000). Local delivery of antimicrobial agents for treatment of peridontal diseases. Eur J Pharm Biopharm 50:83–99.
  • Smistad, G., Jacobsen, J., Sande, S. A. (2007). Multivariate toxicity screening of liposomal formulations on a human buccal cell line. Int J Pharm 330:14–22.
  • Soysa, N. S., Samaranayake, L. P., Ellepola, A. N. B. (2008). Antimicrobials as a contributory factor in oral candidosis—a brief overview. Oral Dis 14:138–143.
  • Sveinsson, S. J., Holbrook, W. P. (1993). Oral mucosal adhesive ointment containing liposomal corticosteroid. Int J Pharm 95:105–109.
  • Szoka, F., Jacobson, K., Derzko, Z., Papahadjopoulos, D. (1980). Fluorescence studies on the mechanism of liposome-cell interactions in vitro. Biochim Biophys Acta 600:1–18.
  • Thaweboon, S., Thaweboon, B, Srithavaj, T., Choonharuangdej, S. (2008). Oral colonization of Candida species in patients receiving radiotherapy in the head and neck area. Quint Int 39:e52–e57.
  • Tsai, H., Bobek, L. A. (1998). Human salivary histatins: promising antifungal therapeutic agents. Crit Rev Oral Biol Med 9:480–497.
  • Yamada-Okabe, T., Mio, T., Ono, N., Kashima, Y., Matsui, M., Arisawa, M., et al. (1999). Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans. J Bacteriol 181:7243–7247.
  • Yang, T. Z., Wang, X. T., Yan, X. Y., Zhang, Q. (2002). Phospholipid deformable vesicles for buccal delivery of insulin. Chem Pharm Bull 50:749–753.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.